Subscribe To
Fda slams brakes on legend biotech's car-t therapy trial in lymphoma patients
The FDA has instituted a clinical hold on Legend Biotech Corporation's (NASDAQ: LEGN) Phase 1 trial for LB1...
February 15, 2022, 9:39 am
Supply chain issues overshadow tesla's earnings beat
Tesla Inc (NASDAQ:TSLA) is down 3.8% to trade at $901.55 at last check, despite the electric vehicle (...
January 27, 2022, 10:27 am
Supply chain issues overshadow tesla's earnings beat
Tesla Inc (NASDAQ:TSLA) is down 3.8% to trade at $901.55 at last check, despite the electric vehicle (...
January 27, 2022, 10:27 am
Supply chain issues overshadow tesla's earnings beat
Tesla Inc (NASDAQ:TSLA) is down 3.8% to trade at $901.55 at last check, despite the electric vehicle (...
January 27, 2022, 10:27 am
Liquidia receives favorable ruling in inter partes review against united therapeutics patent
MORRISVILLE, N.C., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the U.S. Patent Trial and Appeal Board (...
October 8, 2021, 5:23 pm
Liquidia receives favorable ruling in inter partes review against united therapeutics patent
MORRISVILLE, N.C., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the U.S. Patent Trial and Appeal Board (...
October 8, 2021, 5:23 pm
Liquidia receives favorable ruling in inter partes review against united therapeutics patent
MORRISVILLE, N.C., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the U.S. Patent Trial and Appeal Board (...
October 8, 2021, 5:23 pm